Callan JMB Secures 60% Revenue Share in Cavalry 1838 Equine Biosciences Deal
Event summary
- Callan JMB signs long-term operational support agreement with Cavalry 1838, securing 60% of enterprise revenue.
- Deal expands Atlas Complex strategy, targeting $12M–$25M annual revenue for Cavalry 1838 within seven years.
- Atlas Complex to provide integrated infrastructure including regulatory compliance and logistics services.
- Cavalry 1838 will operate from the Equine Center at Atlas Complex in Marion, Alabama.
The big picture
Callan JMB's deal with Cavalry 1838 reinforces its strategy of building a healthcare and life sciences campus where firms can leverage shared operational infrastructure. This approach reduces capital expenditures for tenants while positioning Callan JMB as a key player in the growing biologics logistics market. The recurring revenue model from such partnerships could become a significant growth driver.
What we're watching
- Revenue Diversification
- How Callan JMB's recurring revenue model will scale with additional Atlas Complex partnerships.
- Operational Efficiency
- Whether shared infrastructure can reduce capital requirements for life sciences firms at Atlas Complex.
- Market Expansion
- The pace at which Callan JMB secures similar deals in pharmaceutical manufacturing and biologics sectors.